Web results:
A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer’s COVID-19 vaccine, imposing a dramatically accelerated ...
On Jan. 6, a federal court in the Northern District of Texas ordered the expedited release. As of Jan. 12, the FDA hasn’t indicated it intends to appeal. Scientists Requested Data After FDA Licensing. The FDA licensed the Pfizer vaccine on Aug. 23, 2021, just 108 days after Pfizer started producing the records to the agency. During that ...
FIRST BATCH OF DOCUMENTS SHOWS OVER 1,200 VACCINE DEATHS WITHIN FIRST 90 DAYS. The Food and Drug Administration (FDA) released the first batch of documents related to Pfizer’s Covid-19 vaccine after a federal judge ordered that they must comply with a massive Freedom of Information Act (FOIA) request that was filed by a government ...
CHD Says Pfizer and FDA Dropped Data Bombshell on COVID Vaccine Consumers. The Court ordered Pfizer to release 55,000 documents per month starting March 1. Among the first set of documents is a 38 page report that includes 9 pages of adverse events of “special interest”.
Accelerating Digital Technology for the COVID-19 Vaccine Rollout. March 2022. Pfizer and BioNTech’s embrace of novel mRNA science played a pivotal role in achieving a record-breaking COVID-19 vaccine rollout. But a lesser-known part of this success story is Pfizer’s rapid adoption of new digital technologies to ensure the vaccine reached ...
Fact Check Sep 22, 2023 by: Alexis Tereszcuk Share Tweet Old Settlement Did Pfizer recently agree to pay $2.3 billion for medical fraud, the largest health care fraud settlement in the history of the U.S. Department of Justice? No, that's not true: Pfizer did agree to pay such a settlement in 2009, but not in 2023.
Ended due to lack of efficacy. Trial results published in Annals of Internal Medicine. Clinical Trial Record; Paper on trial results; ACTIV-3 Inpatient: PF-07304814 (Intravenous) New, selective inhibitor of the SARS-CoV-2 3CLpro (a viral protease) developed by Pfizer. Enrollment closed at company’s request. Clinical Trial Record; ACTIV-3 ...
TrialSite has tracked attorney Aaron Siri and his client’s Freedom of Information Act (FOIA) case against Pfizer for full disclosure of clinical trials documentation. Siri shared in a previous post that the Food and Drug Administration (FDA) asked a federal judge to delay the full disclosure of all relevant documentation till 2076—55 years ...
After years of protracted litigation with the pharmaceutical behemoth, Nigerian families reached a $75 million out-of-court settlement sealed with a confidentiality clause. A separate whistleblower lawsuit filed by Pfizer’s former associate medical director for central research and Yale pediatric infectious disease specialist, Juan ...
Federal health advisers have narrowly backed an experimental vaccine from Pfizer that could become the first shot to protect older adults against the respiratory illness known as RSV.